publication date: Apr. 12, 2019

An Appreciation

Paul Godley, oncologist and disparities researcher, dies at 61

By Otis W. Brawley

Paul Godley died after a brief illness on March 31. He was the Rush S. Dickson Distinguished Professor of Hematology and Oncology in the School of Medicine, a professor of epidemiology at the Gillings School of Global Public Health, and senior fellow at the Sheps Center for Health Services Research at the University of North Carolina, Chapel Hill.

He was a beloved and respected colleague in the oncology community, having made significant contributions as a clinician, researcher, mentor, and administrator.

Paul Alphonso Godley was born on April 20, 1957, in Detroit. His father was a physician and his mother was a nurse.  He attended and graduated from the Friends School in Detroit, college at Yale, and medical school at Harvard.

Later he would obtain a master’s degree from the Harvard Kennedy School of Government and a Ph.D. in epidemiology from the Gillings School of Global Public Health at the UNC Chapel Hill.  Paul trained in Internal Medicine at Case Western Reserve University and Medical Oncology at UNC Chapel Hill.

He joined the faculty in the Department of Medicine at UNC and became a member of the UNC Lineberger Cancer Center.  His research in prostate cancer would include leadership roles in several large NCI studies of prostate cancer screening and prevention.

His work would lead to a better understanding of the complexities of prostate cancer screening.  Throughout his career, Paul also studied and worked to eliminate racial disparities in health.  He was director of the Program on Ethnicity, Culture, and Health Outcomes, … Continue reading Paul Godley, oncologist and disparities researcher, dies at 61

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.